Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viking Therapeutics (VKTX) Total Non-Current Liabilities: 2014-2024

Historic Total Non-Current Liabilities for Viking Therapeutics (VKTX) over the last 9 years, with Dec 2024 value amounting to $630,000.

  • Viking Therapeutics' Total Non-Current Liabilities fell 57.88% to $318,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $318,000, marking a year-over-year decrease of 57.88%. This contributed to the annual value of $630,000 for FY2024, which is 32.69% down from last year.
  • Viking Therapeutics' Total Non-Current Liabilities amounted to $630,000 in FY2024, which was down 32.69% from $936,000 recorded in FY2023.
  • In the past 5 years, Viking Therapeutics' Total Non-Current Liabilities ranged from a high of $1.3 million in FY2022 and a low of $29,000 during FY2020.
  • Over the past 3 years, Viking Therapeutics' median Total Non-Current Liabilities value was $936,000 (recorded in 2023), while the average stood at $942,000.
  • Data for Viking Therapeutics' Total Non-Current Liabilities shows a maximum YoY plummeted of 91.94% (in 2020) over the last 5 years.
  • Yearly analysis of 4 years shows Viking Therapeutics' Total Non-Current Liabilities stood at $29,000 in 2020, then reached $1.3 million in 2022, then decreased by 25.71% to $936,000 in 2023, then tumbled by 32.69% to $630,000 in 2024.